Market Closed

ACRS
Aclaris Therapeutics
$ 3.92
-2.00%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago

Aclaris Therapeutics News

Latest Aclaris Therapeutics Stock News & ACRS Headlines

Aclaris Therapeutics (NASDAQ:ACRS) vs. Oncocyte (NASDAQ:IMDX) Financial Contrast
10 days ago | defenseworld.net
Aclaris Therapeutics (ACRS) Reports Q3 Loss, Beats Revenue Estimates
11 days ago | zacks.com
Aclaris Therapeutics, Inc. (ACRS) Discusses ATI-052 Proof-of-Concept Results in Atopic Dermatitis and Asthma Transcript
19 days ago | seekingalpha.com
Aclaris Therapeutics Announces Pricing of $50.0 Million Offering of Common Stock and Pre-Funded Warrants
20 days ago | globenewswire.com
Aclaris Therapeutics, Inc. (ACRS) – What Are Analysts Saying About This Stock?
22 days ago | defenseworld.net
Are Medical Stocks Lagging Aclaris Therapeutics (ACRS) This Year?
a month ago | zacks.com
Aclaris (ACRS) Soars 6.0%: Is Further Upside Left in the Stock?
2 months ago | zacks.com
Deutsche Bank AG Makes New Investment in Aclaris Therapeutics, Inc. $ACRS
3 months ago | defenseworld.net
Wall Street Analysts Believe Aclaris (ACRS) Could Rally 69.2%: Here's is How to Trade
3 months ago | zacks.com
Aclaris Therapeutics (ACRS) Reports Q2 Loss, Tops Revenue Estimates
3 months ago | zacks.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

ACRS
Aclaris Therapeutics
$ 3.92
-2.00%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago